BEDINI, ANNALIDA
 Distribuzione geografica
Continente #
NA - Nord America 13.228
EU - Europa 8.752
AS - Asia 4.138
SA - Sud America 371
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 70
OC - Oceania 12
AN - Antartide 1
Totale 26.857
Nazione #
US - Stati Uniti d'America 12.992
GB - Regno Unito 2.150
CN - Cina 2.064
NL - Olanda 1.973
IT - Italia 1.169
SG - Singapore 1.101
UA - Ucraina 896
SE - Svezia 529
RU - Federazione Russa 509
FI - Finlandia 428
DE - Germania 409
TR - Turchia 371
BR - Brasile 263
FR - Francia 220
IE - Irlanda 192
VN - Vietnam 176
CA - Canada 145
IN - India 104
HK - Hong Kong 60
BE - Belgio 47
BD - Bangladesh 42
ES - Italia 40
AR - Argentina 38
PL - Polonia 38
JP - Giappone 34
KR - Corea 32
MX - Messico 30
AT - Austria 23
ID - Indonesia 23
RO - Romania 22
IQ - Iraq 20
EU - Europa 18
CO - Colombia 16
EG - Egitto 16
ZA - Sudafrica 16
KE - Kenya 15
AL - Albania 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
CR - Costa Rica 12
EC - Ecuador 12
PK - Pakistan 12
PT - Portogallo 12
SA - Arabia Saudita 12
CL - Cile 11
HN - Honduras 10
JM - Giamaica 10
AU - Australia 9
EE - Estonia 9
PE - Perù 9
MY - Malesia 8
VE - Venezuela 8
IL - Israele 7
KZ - Kazakistan 7
PH - Filippine 7
PY - Paraguay 7
UZ - Uzbekistan 7
DK - Danimarca 6
GR - Grecia 6
IR - Iran 6
MA - Marocco 6
NI - Nicaragua 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
CZ - Repubblica Ceca 4
JO - Giordania 4
NP - Nepal 4
PA - Panama 4
SI - Slovenia 4
SV - El Salvador 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BZ - Belize 3
HU - Ungheria 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
GU - Guam 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
PR - Porto Rico 2
RS - Serbia 2
SC - Seychelles 2
SM - San Marino 2
Totale 26.575
Città #
Amsterdam 1.944
Southend 1.893
Dallas 1.226
Woodbridge 1.169
Ashburn 1.111
Fairfield 968
Houston 765
Jacksonville 711
Ann Arbor 681
San Jose 606
Chandler 588
Singapore 555
Cambridge 446
Wilmington 395
Seattle 382
Nanjing 352
Beijing 328
Boardman 277
Urbino 276
Izmir 258
Council Bluffs 215
Los Angeles 195
Helsinki 194
Dublin 188
Chicago 181
New York 171
Nanchang 153
San Mateo 113
Princeton 108
Lauterbourg 101
Santa Clara 98
Düsseldorf 86
Shenyang 83
Munich 81
Hebei 78
Changsha 77
Tianjin 76
Salt Lake City 70
Des Moines 66
Ho Chi Minh City 66
Istanbul 65
Jiaxing 56
Hong Kong 52
Toronto 47
San Francisco 46
Brussels 45
London 45
Kunming 43
Moscow 42
Shanghai 42
Tampa 40
Elk Grove Village 39
Buffalo 38
Hanoi 38
Jinan 38
Velikiy Novgorod 38
Orem 37
Montreal 36
Turku 36
Bremen 35
Guangzhou 35
Hangzhou 35
Nuremberg 32
São Paulo 32
Venice 31
Frankfurt am Main 30
Rome 30
Warsaw 30
Milan 28
San Diego 28
North Bergen 27
Brooklyn 25
Phoenix 24
Seongnam 24
Zhengzhou 24
Chennai 23
Denver 23
Ningbo 22
Stockholm 22
Tokyo 22
Bellaria-Igea Marina 21
Mülheim 20
Haikou 19
Sterling 19
Dulles 18
Wuppertal 18
Bologna 17
Changchun 17
Lancaster 17
Manchester 17
Tavullia 17
The Dalles 17
Atlanta 16
Augusta 16
Boston 16
Parma 15
Lanzhou 14
Miami 14
Poplar 14
Norwalk 13
Totale 19.071
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.210
Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey. 725
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 443
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 400
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 397
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 345
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 341
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 337
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 320
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 311
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 309
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 306
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 300
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 298
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 293
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 288
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 286
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 284
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 284
Synthesis and Biological Activity of new melatonin dimeric derivatives. 282
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 282
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 279
An improved route to cycloalka[b]pyrrole 2-carboxylates 275
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 275
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 273
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 272
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 270
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 254
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 253
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 250
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 242
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 239
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 233
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 231
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 231
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 231
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 230
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 230
The rationale for the development of melatonin receptor ligands 229
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 227
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 224
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 223
Synthetic Melatonin Receptor Ligands 222
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 221
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 220
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 218
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 218
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 217
Homology models of melatonin receptors: challenges and recent advances 216
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 214
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 211
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 210
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 208
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 201
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 196
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 194
A novel melatonin partial agonist with sleep-promoting properties 194
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 192
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 192
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 191
Strategies leading to MT2 selective melatonin receptor antagonists 187
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 185
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 183
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 182
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 182
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 181
Melatonin receptor agonists: new options for insomnia and depression treatment 181
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 181
Strategies leading to MT2 selective melatonin receptor antagonists 179
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 178
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 177
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 176
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 172
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 170
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 170
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 170
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability 167
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 166
A novel melatonin partial agonist with sleep-promoting properties. 166
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 164
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 163
Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors 162
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 158
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 153
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 150
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 150
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 146
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 146
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 144
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 142
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 139
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 139
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 138
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 138
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 137
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 134
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 134
Advances on the Development of Subtype Selective Melatonin Ligands 133
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 131
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 129
Totale 25.330
Categoria #
all - tutte 87.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022886 0 0 0 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024565 32 58 28 77 40 100 32 13 67 57 18 43
2024/20252.718 136 105 428 110 67 162 277 109 167 159 247 751
2025/20267.478 433 657 1.177 772 384 384 618 168 2.151 378 248 108
2026/20271.285 246 144 487 408 0 0 0 0 0 0 0 0
Totale 26.857